UnknownNot applicableNCT03873285
Method of Genetic Analysis in Genodermatoses
Studying Rare genetic disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Queen Fabiola Children's University Hospital
- Principal Investigator
- Deborah Salik, MD, RPTHôpital Universitaire Des Enfants Rein Fabiola
- Intervention
- Genetic diagnostic by mendeliome or genome(genetic)
- Enrollment
- 100 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2021
Study locations (1)
- Hôpital Universitaire Des Enfants Rein Fabiola, Brussels, Belgium
Collaborators
Center of Human Genetics - ULB in Brussels · Interuniversity Institute of Bioinformatics in Brussels
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03873285 on ClinicalTrials.govOther trials for Rare genetic disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06926127Genomic Profiling of Genetic and Rare DiseasesFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT06796751PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read SequencingIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06314490Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2AUniversity of California, San Diego
- ACTIVE NOT RECRUITINGNANCT05064241Overcoming Barriers to Accessing Genetic MedicineBoston Children's Hospital
- RECRUITINGNANCT05499091Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGINUniversity Hospital, Angers
- ENROLLING BY INVITATIONNCT05236595Research for Individualized Therapeutics in Rare Genetic DiseaseMayo Clinic
- RECRUITINGNCT04586075UW Undiagnosed Genetic Diseases ProgramUniversity of Wisconsin, Madison
- RECRUITINGNCT03967743Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic DisordersBoston Children's Hospital